These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29304403)

  • 21. Supramolecular Modular Approach toward Conveniently Constructing and Multifunctioning a pH/Redox Dual-Responsive Drug Delivery Nanoplatform for Improved Cancer Chemotherapy.
    Liu J; Liu X; Yuan Y; Li Q; Chang B; Xu L; Cai B; Qi C; Li C; Jiang X; Wang G; Wang Z; Wang L
    ACS Appl Mater Interfaces; 2018 Aug; 10(31):26473-26484. PubMed ID: 29893551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel PEI/Poly-γ-Gutamic Acid Nanoparticles for High Efficient siRNA and Plasmid DNA Co-Delivery.
    Peng SF; Hsu HK; Lin CC; Cheng YM; Hsu KH
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28054985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanistic study of transfection of chitosan/DNA complexes coated by anionic poly(γ-glutamic acid).
    Liao ZX; Peng SF; Ho YC; Mi FL; Maiti B; Sung HW
    Biomaterials; 2012 Apr; 33(11):3306-15. PubMed ID: 22281422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual-targeting nanoparticles with core-crosslinked and pH/redox-bioresponsive properties for enhanced intracellular drug delivery.
    Zhao J; Yan C; Chen Z; Liu J; Song H; Wang W; Liu J; Yang N; Zhao Y; Chen L
    J Colloid Interface Sci; 2019 Mar; 540():66-77. PubMed ID: 30634060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HER2 Targeted Breast Cancer Therapy with Switchable "Off/On" Multifunctional "Smart" Magnetic Polymer Core-Shell Nanocomposites.
    Vivek R; Thangam R; Kumar SR; Rejeeth C; Kumar GS; Sivasubramanian S; Vincent S; Gopi D; Kannan S
    ACS Appl Mater Interfaces; 2016 Jan; 8(3):2262-79. PubMed ID: 26771508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple hyperthermia-mediated release of TRAIL/SPION nanocomplex from thermosensitive polymeric hydrogels for combination cancer therapy.
    Zhang ZQ; Song SC
    Biomaterials; 2017 Jul; 132():16-27. PubMed ID: 28399459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monensin, a polyether ionophore antibiotic, overcomes TRAIL resistance in glioma cells via endoplasmic reticulum stress, DR5 upregulation and c-FLIP downregulation.
    Yoon MJ; Kang YJ; Kim IY; Kim EH; Lee JA; Lim JH; Kwon TK; Choi KS
    Carcinogenesis; 2013 Aug; 34(8):1918-28. PubMed ID: 23615398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fabrication of chitosan based nanocomposite with legumain sensitive properties using charge driven self-assembly strategy.
    Luo M; Li Q; Wang D; Ge C; Wang J; Nan K; Lin S
    J Mater Sci Mater Med; 2018 Aug; 29(9):142. PubMed ID: 30121849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells.
    Cao N; Cheng D; Zou S; Ai H; Gao J; Shuai X
    Biomaterials; 2011 Mar; 32(8):2222-32. PubMed ID: 21186059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
    Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-delivery of siRNA and hypericin into cancer cells by hyaluronic acid modified PLGA-PEI nanoparticles.
    Li Y; Zhang J; Wang B; Shen Y; Ouahab A
    Drug Dev Ind Pharm; 2016; 42(5):737-46. PubMed ID: 26472259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. XIAP-targeting drugs re-sensitize PIK3CA-mutated colorectal cancer cells for death receptor-induced apoptosis.
    Ehrenschwender M; Bittner S; Seibold K; Wajant H
    Cell Death Dis; 2014 Dec; 5(12):e1570. PubMed ID: 25501831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacterial-Derived Polymer Poly-y-Glutamic Acid (y-PGA)-Based Micro/Nanoparticles as a Delivery System for Antimicrobials and Other Biomedical Applications.
    Khalil IR; Burns AT; Radecka I; Kowalczuk M; Khalaf T; Adamus G; Johnston B; Khechara MP
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28157175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy.
    Li Y; Liu G; Ma J; Lin J; Lin H; Su G; Chen D; Ye S; Chen X; Zhu X; Hou Z
    J Control Release; 2017 Jul; 258():95-107. PubMed ID: 28501673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mesenchymal stem cells as a novel carrier for targeted delivery of gene in cancer therapy based on nonviral transfection.
    Hu YL; Huang B; Zhang TY; Miao PH; Tang GP; Tabata Y; Gao JQ
    Mol Pharm; 2012 Sep; 9(9):2698-709. PubMed ID: 22862421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial division inhibitor 1 (mdivi-1) enhances death receptor-mediated apoptosis in human ovarian cancer cells.
    Wang J; Hansen K; Edwards R; Van Houten B; Qian W
    Biochem Biophys Res Commun; 2015 Jan; 456(1):7-12. PubMed ID: 25446129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioresponsive functional nanogels as an emerging platform for cancer therapy.
    Huang D; Qian H; Qiao H; Chen W; Feijen J; Zhong Z
    Expert Opin Drug Deliv; 2018 Jul; 15(7):703-716. PubMed ID: 29976103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. D-SP5 Peptide-Modified Highly Branched Polyethylenimine for Gene Therapy of Gastric Adenocarcinoma.
    Li X; Xie Z; Xie C; Lu W; Gao C; Ren H; Ying M; Wei X; Gao J; Su B; Ren Y; Liu M
    Bioconjug Chem; 2015 Aug; 26(8):1494-503. PubMed ID: 26052814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic targeting of CD95 and the TRAIL death receptors.
    Gerspach J; Pfizenmaier K; Wajant H
    Recent Pat Anticancer Drug Discov; 2011 Sep; 6(3):294-310. PubMed ID: 21762072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TRAIL receptor signalling and modulation: Are we on the right TRAIL?
    Mahalingam D; Szegezdi E; Keane M; de Jong S; Samali A
    Cancer Treat Rev; 2009 May; 35(3):280-8. PubMed ID: 19117685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.